Opinion of the High Council for Public Health dated December 17, 2010, regarding the mandatory minimum information requirements for advertising the intradermal seasonal influenza vaccine Intanza® 15 µg
Author(s): Haut Conseil de la Santé Publique
Publishing year: 2011
Pages: 152
Weekly Epidemiological Bulletin, 2011, n° 10-11, p. 152
In relation to
Our latest news
news
Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...
news
Andes Hantavirus: Implementation of epidemiological investigations and...
news
